Literature DB >> 21659725

Suicidal behavior in prodromal Huntington disease.

Jess G Fiedorowicz1, James A Mills, Adam Ruggle, Douglas Langbehn, Jane S Paulsen.   

Abstract

BACKGROUND: Several studies have suggested a greater risk of suicide in Huntington disease (HD); however, unique risk factors for suicide in HD are not established.
OBJECTIVE: We sought to determine risk factors for suicidal behavior, defined as suicide or attempted suicide, in prodromal HD.
METHODS: From the prospective PREDICT-HD cohort, we identified 735 cases with HD gene expansion but no manifest symptoms of HD and 194 non-gene-expanded controls. In survival analysis, a number of potential risk factors for suicidal behavior were assessed, including symptoms of depression, hopelessness, substance abuse, marital status, gender, and psychiatric history.
RESULTS: During a mean of 3.7 years of prospective follow-up, 12 cases (1.6%) attempted suicide and 1 completed suicide (0.1%). No suicides were observed among controls. In univariate Cox proportional hazards regression models, a history of suicide attempts (HR 8.5, 95% CI 2.8-26.1, p < 0.0002) and a Beck Depression Inventory II score >13 (HR 7.2, 95% CI 2.3-22.0, p < 0.0006) were associated with suicidal behavior. These risk factors had independent effects in multivariate models. A history of incarceration in the past 2 years was also associated (HR 12.5, 95% CI 2.7-56.6, p < 0.002), though uncommon. No further risk factors were identified.
CONCLUSION: A history of suicide attempts and the presence of depression are strongly predictive of suicidal behavior in prodromal HD. As these risk factors are among the most robust risk factors for suicide, established suicide risk factors appear applicable to those with prodromal HD.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21659725      PMCID: PMC3186721          DOI: 10.1159/000327754

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  58 in total

1.  Huntington's chorea in Michigan. I. Demography and genetics.

Authors:  T E REED; J H CHANDLER
Journal:  Am J Hum Genet       Date:  1958-06       Impact factor: 11.025

Review 2.  Huntington's disease genetics.

Authors:  Richard H Myers
Journal:  NeuroRx       Date:  2004-04

3.  Prevalence of and risk factors for suicide attempts versus suicide gestures: analysis of the National Comorbidity Survey.

Authors:  Matthew K Nock; Ronald C Kessler
Journal:  J Abnorm Psychol       Date:  2006-08

Review 4.  Huntington's disease.

Authors:  Francis O Walker
Journal:  Lancet       Date:  2007-01-20       Impact factor: 79.321

5.  Early cognitive deficits in Swedish gene carriers of Huntington's disease.

Authors:  Tarja-Brita Robins Wahlin; Anders Lundin; Keith Dear
Journal:  Neuropsychology       Date:  2007-01       Impact factor: 3.295

Review 6.  Clinical assessment of suicide risk in depressive disorder.

Authors:  William H Coryell
Journal:  CNS Spectr       Date:  2006-06       Impact factor: 3.790

7.  Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years.

Authors:  Lauren B Marangell; Mark S Bauer; Ellen B Dennehy; Stephen R Wisniewski; Michael H Allen; David J Miklowitz; Maria A Oquendo; Ellen Frank; Roy H Perlis; James M Martinez; Andrea Fagiolini; Michael W Otto; Cheryl A Chessick; Holly A Zboyan; Sachiko Miyahara; Gary Sachs; Michael E Thase
Journal:  Bipolar Disord       Date:  2006-10       Impact factor: 6.744

8.  Preparing for preventive clinical trials: the Predict-HD study.

Authors:  Jane S Paulsen; Michael Hayden; Julie C Stout; Douglas R Langbehn; Elizabeth Aylward; Christopher A Ross; Mark Guttman; Martha Nance; Karl Kieburtz; David Oakes; Ira Shoulson; Elise Kayson; Shannon Johnson; Elizabeth Penziner
Journal:  Arch Neurol       Date:  2006-06

9.  Depression and stages of Huntington's disease.

Authors:  Jane S Paulsen; Carissa Nehl; Karin Ferneyhough Hoth; Jason E Kanz; Michelle Benjamin; Rachel Conybeare; Bradley McDowell; Beth Turner
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

10.  HUNTINGTON'S CHOREA IN VICTORIA AND TASMANIA.

Authors:  C R BROTHERS
Journal:  J Neurol Sci       Date:  1964 Sep-Oct       Impact factor: 3.181

View more
  13 in total

Review 1.  Therapy in Huntington's disease: where are we?

Authors:  Martha A Nance
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Authors:  Noelle E Carlozzi; Siera Goodnight; Anna L Kratz; Julie C Stout; Michael K McCormack; Jane S Paulsen; Nicholas R Boileau; David Cella; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2019

3.  Suicide risk around the world: a meta-analysis of longitudinal studies.

Authors:  E M Guzmán; C B Cha; J D Ribeiro; J C Franklin
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-09-04       Impact factor: 4.328

4.  Suicidal Ideation Assessment in Individuals with Premanifest and Manifest Huntington Disease.

Authors:  Melissa Wesson; Nicholas R Boileau; Joel S Perlmutter; Jane S Paulsen; Stacey K Barton; Michael K McCormack; Noelle E Carlozzi
Journal:  J Huntingtons Dis       Date:  2018

5.  Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.

Authors:  Eric A Epping; James A Mills; Leigh J Beglinger; Jess G Fiedorowicz; David Craufurd; Megan M Smith; Mark Groves; Kelly R Bijanki; Nancy Downing; Janet K Williams; Jeffrey D Long; Jane S Paulsen
Journal:  J Psychiatr Res       Date:  2013-06-19       Impact factor: 4.791

Review 6.  Genetic testing for neurodegenerative diseases: Ethical and health communication challenges.

Authors:  J Scott Roberts; Anne K Patterson; Wendy R Uhlmann
Journal:  Neurobiol Dis       Date:  2020-04-14       Impact factor: 5.996

Review 7.  Impaired mitochondrial function in psychiatric disorders.

Authors:  Husseini Manji; Tadafumi Kato; Nicholas A Di Prospero; Seth Ness; M Flint Beal; Michael Krams; Guang Chen
Journal:  Nat Rev Neurosci       Date:  2012-04-18       Impact factor: 34.870

8.  Reverse pre-symptomatic testing for Huntington disease: double disclosure when 25% at-risk children reveal the genetic status to their parent.

Authors:  Adeline Bonnard; Ariane Herson; Marcela Gargiulo; Alexandra Durr
Journal:  Eur J Hum Genet       Date:  2018-09-11       Impact factor: 4.246

Review 9.  Neuropsychiatric Burden in Huntington's Disease.

Authors:  Ricardo Augusto Paoli; Andrea Botturi; Andrea Ciammola; Vincenzo Silani; Cecilia Prunas; Claudio Lucchiari; Elisa Zugno; Elisabetta Caletti
Journal:  Brain Sci       Date:  2017-06-16

10.  Age at Death and Causes of Death in Patients with Huntington Disease in Norway in 1986-2015.

Authors:  Olga Karin Solberg; Petra Filkuková; Jan C Frich; Kristin J Billaud Feragen
Journal:  J Huntingtons Dis       Date:  2018
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.